期刊文献+

c-af-1反义寡核苷酸转染对人卵巢癌SKOV_3细胞增殖的抑制作用 被引量:1

Inhibitory effects of c-raf-1 antisense oligodeoxynucleotides transfactionon proliferation of the human ovarian carcinoma SKOV_3 cell lines
下载PDF
导出
摘要 目的:探讨c-raf-1基因反义寡核苷酸转染对人卵巢癌SKOV3细胞增殖的抑制作用及其分子机制。方法:实验分3组:正常对照组、c-raf-1正义治疗组、c-raf-1反义治疗组。脂质体转染后不同时间分别进行M TT试验、集落形成试验、荧光显微镜检测、蛋白质荧光强度测定,以观察不同条件处理后各组细胞的增殖、凋亡、蛋白质表达有无差别。结果:反义治疗组与正义治疗组比较:转染72h OD值分别0.272与1.307(P<0.05);克隆形成率分别为30.6%与75.0%(P<0.05);凋亡率分别为19.7%与9.2%(P<0.05),同时明显地下调P74蛋白质的表达水平(P<0.05)。结论:c-raf-1反义寡核苷酸对人卵巢癌SKOV3细胞的增殖有明显的抑制作用。 Objective: To investigate the effects and the mechanisms of c-raf-1 genes antisense oligodeoxynucleotides ( ASODN ) transfection in inhibiting the human ovarian carcinoma SKOV3 cell lines. Methods: There were 3 groups in our study: normal control group, c-raf-1 sense oligodeoxynucleotides ( SODN ) experimental group, and c-raf-1 antisense experimental group, at the different time points after liposome-mediated transfection, the cell proliferation, apoptosis, protein expressing level were observed by MTT assay, flow cytometry, fluorescent microscope and cloning test. Results: In the ASODN experimental group and SODN group, the OD-value were 0.272 and 1.307 respectively ( P〈0.05 ) 72h after transfection; the cloning efficiency were 30.6% and 75.0% respectively ( P〈0.05 ) ; the apoptosis rate were 19.7% and 9.2% respectively ( P〈0.05 ) and the level of P74 protein was decreased statistically in c-raf-1 ASODN group. Conclusions: The proliferation of the human ovarian carcinoma SKOV3 cell lines can be inhibited by the c-raf-1 ASODN.
出处 《重庆医科大学学报》 CAS CSCD 2006年第1期19-22,41,共5页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(No.30070230)
关键词 SKOV 细胞 反义寡核苷酸 卵巢癌 C-RAF-1 SKOV3 cell lines Antisense oligodeoxynucleotides Ovarian carcinoma c-raf-1
  • 相关文献

参考文献9

  • 1Wadler S.New developments in treatment of ovarian cancer[J].Expert Opin Investig Drugs,2001; 10(6):1167-1 172.
  • 2Harries M,Kaye SB.Recent advances in the treatment of epithelial ovarian cancer[J].Expert Opin Investig Drugs,2001;10(9):1715-1724.
  • 3Ozols Robert F.Future directions in the treatment of ovarian cancer[J].Semin Oncol,2002;29(1 supp1):32-42.
  • 4O' Dwyer PJ,Stevenson JP,Gallagher M,et al.C-raf-1 depletion and tumor responses in patients treated with the c-raf-1antisense oligodeoxynucleotide IsIs 5132 (CGP 68936A)[J].Clin Cancer Res,1999;5 (12):3977-3982.
  • 5Kim CK,Haider KhH,Choi SH.Nonviral vector for efficient gene transfer to human ovarian adenocarcinoma cells[J].Gynecol Oncol,2002;84(1):85-93.
  • 6Stevenson JP,Kang-Shen Yao,Gallagher M,et al.Phase Ⅰclinical pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense ologonucleotide ISIS 5132 (CGP6984A)[J].J Clin Oncol,1999; 17(7):2227-2236.
  • 7Winer MA,Wadewitz AG,Wolgemuth DJ.Members of the raf gene family exhibit segment-specific patterns of expression in mouse epididymis[J].Mol Reprod Dev,1993;35(1):16-23.
  • 8Cuningham CC,Holmulund JT,Schiller JH,et al.A phase Ⅰtrial of c-raf-1 kinase antisense oligonucleotide ISIS 5132 administered as a continuous intravenous infusion in patients with advanced cancer[J].Clin Cancer Res,2000;6(5):1626-1631.
  • 9Vaughn JP,Iglehart JD,Demirdji S,et al.Antisense DNA downregulation of the erbB-2 oncogene measured by a flow cytometric assay[J].Proc Natl Acad Sci USA,1995;92:8338-8342.

同被引文献7

  • 1Zebisch A,Czernilofsky AP,Keri G,et al.Signaling Through RAS-RAF-MEK-ERK:from Basics to Bedside[J].Curr Med Chem,2007; 14(5):601-623.
  • 2Al-Mulla F,Hagan S,Behbehani A,et al.Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients[J].J Clin Oncol,2006; 24(36):5672-5679.
  • 3Gupta AK,Bakanauskas VJ,Cerniglia GJ,et al.The ras radiation resistance pathway[J].Cancer Res,2001;61(10):4278-4282.
  • 4Kasid U.Raf-1 protein kinase,signal transduction,and targeted intervention of radiation response[J].Exp Biol Med (Maywood),2001;226(7):624-625.
  • 5Kasid U,Suy S,Dent P,et al.Activation of raf by ionizing radiation[J].Nature,1996;29(382):813-816.
  • 6Johnes HA,Hahm SM,Bernhard E,et al.Ras inhibitors and radiation therapy[J].Semin Radiat Oncol,2001; 11 (4):328-337.
  • 7Tang WY,Chau SP,Tsang WP,et al.The role of Raf-1 in radiation resistance of human hepatocellular carcinoma Hep G2 cells[J].Oncol Rep,2004; 12(6):1349-1354.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部